Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register

BACKGROUND: Anti-tumour necrosis factor (TNF)α treatments improve outcome in severe rheumatoid arthritis (RA) and are efficacious in psoriasis and psoriatic arthritis. However recent case reports describe psoriasis occurring as an adverse event in patients with RA receiving anti-TNFα therapy. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, M J, Dixon, W G, Watson, K D, King, Y, Groves, R, Hyrich, K L, Symmons, D P M
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605571/
https://www.ncbi.nlm.nih.gov/pubmed/18385277
http://dx.doi.org/10.1136/ard.2007.087288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605571/
https://www.ncbi.nlm.nih.gov/pubmed/18385277
http://dx.doi.org/10.1136/ard.2007.087288

Ejemplares similares